Understanding the mechanism of benefits of dapagliflozin in HFpEF: An invasive hemodynamic randomized trial

Atorvastatin associated with reduced cardiac dysfunction in lymphoma patients treated with anthracycline: The STOP-CA trial

The BIOVASC trial shows non-inferiority of the ICR approach to SCR with better primary composite outcomes

Apixaban proves to be more effective than LMWH and equally safe in thetreatment of cancer-associated VTE

Aggressive lipid-lowering with evolocumab stabilizing plaque in stable CAD demonstrated in multimodality imaging: The YELLOW III study

Incorporation of sotatercept into the background PAH therapy proven to be beneficial: The STELLAR phase 3 trial

PFA may offer a time-efficient and safer alternative for drug-refractory AF patients

Implementation of the 2022 HF guidelines for equitable care